Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Algorithm Developed to Predict How and When Proteins Behave Badly

By LabMedica International staff writers
Posted on 05 Mar 2012
Scientists have developed an algorithm that can predict which regions of a protein are susceptible to exposure upon misfolding, and how mutations in the protein and alterations in the cellular environment might affect the stability of these vulnerable regions. More...


The predictions help scientists gain a better determination of protein mechanisms, and may one day help in developing treatments to fight currently lethal neurodegenerative diseases effectively.

Several neurodegenerative diseases--including Alzheimer’s and amyotrophic lateral sclerosis (ALS), recruit and transform healthy proteins to the misfolded form, and amass in large clumps that glue up the processes of the nervous system.

The investigators presented their findings at the 56th annual meeting of the Biophysical Society (BPS), held February 25-29, 2012, in San Diego, CA, USA. The algorithm developed by the researchers utilizes the energy equations of thermodynamics to calculate the likelihood that certain stretches of protein will be displayed when the protein misfolds. Since the exposed regions are specific to the misfolded version of the protein, researchers can use these areas as targets for diagnostic and therapeutic treatments. The algorithm can be modified for different proteins, and it predicts several potential target regions for each protein. The investigators have used it to study neurodegenerative disease-causing proteins as well as misfolded proteins that have been implicated in some cancers.

More recently, the researchers used computer simulations to manipulate proteins in a virtual environment, assessing out how simple it is for mutated proteins to misfold and propagate. Using this application has helped the team predict the progression of hereditary ALS disease. “The fact that we can predict the lifetime of an individual diagnosed with hereditary ALS from simulations of a protein’s mechanical properties is something that is both satisfying and that gives one pause,” said Dr. Steven Plotkin, a biophysicist at the University of British Columbia (Vancouver, Canada) who studies the process of protein misfolding. “We hope that such information might give some clues as to how to develop effective therapies for this disease.”

Related Links:
University of British Columbia
Biophysical Society Annual Meeting


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.